|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-8-3
|
|
pubmed:abstractText |
Whether platinum plus gemcitabine or vinorelbine are equally effective in the treatment of advanced non-small-cell lung cancer (NSCLC) is still controversial, a meta-analysis was performed to compare the gemcitabine plus platinum with vinorelbine plus platinum regimens in first-line treatment of advanced NSCLC.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1872-8332
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
65
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
339-44
|
|
pubmed:meshHeading |
pubmed-meshheading:19144444-Aged,
pubmed-meshheading:19144444-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19144444-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:19144444-Clinical Trials as Topic,
pubmed-meshheading:19144444-Databases, Bibliographic,
pubmed-meshheading:19144444-Deoxycytidine,
pubmed-meshheading:19144444-Disease Progression,
pubmed-meshheading:19144444-Female,
pubmed-meshheading:19144444-Humans,
pubmed-meshheading:19144444-Lung Neoplasms,
pubmed-meshheading:19144444-Male,
pubmed-meshheading:19144444-Middle Aged,
pubmed-meshheading:19144444-Odds Ratio,
pubmed-meshheading:19144444-Platinum,
pubmed-meshheading:19144444-Vinblastine
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
A meta-analysis of platinum plus gemcitabine or vinorelbine in the treatment of advanced non-small-cell lung cancer.
|
|
pubmed:affiliation |
Department of Oncology, Huashan Hospital, Fudan University, Shanghai, China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|
